Rona Jeffrey A's Form 4 filing
Ovid Therapeutics Inc. (OVID) · filed Mar 2, 2026
- Accession no.
- 0001311404-26-000002
- Filed
- Mar 2, 2026
- Trade date
- Feb 23-26, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $12.4K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rona Jeffrey ACIK 0001311404 | Officer (CBFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Common Stock | SSaleDisposed | −8,541 | $1.45 | −$12,384.45 | 88,188 | Direct | |
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +68,125 | $0.00 | $0 | 156,313 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +408,750 | $0.00 | $0 | 408,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.